Shuttle Pharmaceuticals Holdings (SHPH) Other Non Operating Income (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Other Non Operating Income of $76264.0 for Q1 2026, up 2785.51% year-over-year from $2643.0 in Q1 2025, and down 76.6% quarter-over-quarter from $325907.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other Non Operating Income (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $76264.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 2785.51% year-over-year to $76264.0; the TTM figure through Mar 2026 stood at $416271.0 (up 15.45% YoY), while the FY2025 annual figure was $342650.0, down 38.35% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $76264.0, down from $325907.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.2 million in Q1 2023, with the low at -$517687.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is $98313.0 (2023), against an average of $162795.8.
- The sharpest annual moves came in 2023 and 2024: Other Non Operating Income soared 3029.89% in 2023, then slumped 133.11% in 2024.
- Shuttle Pharmaceuticals Holdings' Other Non Operating Income stood at -$517687.0 in 2022, then soared by 118.99% to $98313.0 in 2023, then surged by 119.08% to $215384.0 in 2024, then surged by 51.31% to $325907.0 in 2025, then slumped by 76.6% to $76264.0 in 2026.
- Business Quant data shows SHPH's Other Non Operating Income at $76264.0 in Q1 2026, $325907.0 in Q4 2025, and $2427.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.91 Mn | 1.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76,264.00 |
| Dec 31, 2025 | 325,907.00 |
| Sep 30, 2025 | 2,427.00 |
| Jun 30, 2025 | 11,673.00 |
| Mar 31, 2025 | 2,643.00 |
| Dec 31, 2024 | 215,384.00 |
| Sep 30, 2024 | 286,316.00 |
| Jun 30, 2024 | -143,773.00 |
| Mar 31, 2024 | 197,862.00 |
| Dec 31, 2023 | 98,313.00 |
| Sep 30, 2023 | 442,900.00 |
| Jun 30, 2023 | 434,275.00 |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | -517,687.00 |
| Sep 30, 2022 | 112,797.00 |
| Jun 30, 2022 | -58,422.00 |
| Mar 31, 2022 | 39,650.00 |
| Sep 30, 2021 | 62,500.00 |